Citation: M. Rosler, Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial (vol 318, pg 633, 1999), BR MED J, 322(7300), 2001, pp. 1456-1456
Authors:
Blocher, D
Henkel, K
Retz, W
Retz-Junginger, P
Thorne, J
Rosler, M
Citation: D. Blocher et al., Symptoms from the spectrum of attention-deficit/hyperactivity disorder (ADHD) in sexual delinquents, F NEUR PSYC, 69(10), 2001, pp. 453-459
Citation: A. Dubus et al., Monte Carlo simulation of kinetic electron emission induced by MeV He+ andHe++ ions incident on polycrystalline aluminium, MATH COMP S, 55(1-3), 2001, pp. 37-48
Authors:
Thome, J
Retz, W
Baader, M
Pesold, B
Hu, M
Cowen, M
Durany, N
Adler, G
Henn, FA
Rosler, M
Citation: J. Thome et al., Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease, J NEURAL TR, 108(10), 2001, pp. 1175-1180
Authors:
Stolterfoht, N
Bremer, JH
Hoffmann, V
Niemann, D
Rosler, M
Baragiola, R
Citation: N. Stolterfoht et al., Mechanisms for plasmon production by highly charged neon ions interacting with an Al surface, PHYS SCR, T92, 2001, pp. 227-229
Authors:
Stolterfoht, N
Niemann, D
Hoffmann, V
Rosler, M
Baragiola, RA
Citation: N. Stolterfoht et al., Plasmon production by the decay of hollow Ne atoms near an Al surface - art. no. 052902, PHYS REV A, 6105(5), 2000, pp. 2902
Authors:
Yamamoto, M
Gotz, M
Ozawa, H
Luckhaus, C
Saito, T
Rosler, M
Riederer, P
Citation: M. Yamamoto et al., Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease, BBA-MOL BAS, 1535(1), 2000, pp. 60-68
Citation: M. Rosler, First principles calculation of ion induced kinetic electron emission fromnearly free-electron metals below the plasmon threshold, NUCL INST B, 164, 2000, pp. 873-878
Authors:
Durany, N
Cruz-Sanchez, FF
Thome, J
Hohn, H
Retz, W
Riederer, P
Rosler, M
Citation: N. Durany et al., No association between alpha(1)-antichymotrypsin and apolipoprotein E in Alzheimer's disease and vascular dementia, ALZHEIM REP, 2(3), 1999, pp. 159-164
Citation: M. Rosler, Effectiveness of rivastigmine in Alzheimer's disease - Improvements in functional ability remain unestablished - Reply, BR MED J, 319(7210), 1999, pp. 641-641
Authors:
Rosler, M
Anand, R
Cicin-Sain, A
Gauthier, S
Agid, Y
Dal-Bianco, P
Stahelin, HB
Hartman, R
Gharabawi, M
Citation: M. Rosler et al., Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial, BR MED J, 318(7184), 1999, pp. 633-638
Authors:
Thome, J
Gewirtz, JC
Sakai, N
Zachariou, V
Retz-Junginger, P
Retz, W
Duman, RS
Rosler, M
Citation: J. Thome et al., Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?, NEUROSCI L, 274(1), 1999, pp. 37-40
Authors:
Smidts, OF
Dubus, A
Vidovic, Z
Billebaud, A
Fallavier, M
Kirsch, R
Poizat, JC
Remillieux, J
Rosler, M
Citation: Of. Smidts et al., Theoretical and experimental study of the correlation between forward and backward electron emissions induced by H-0 or H+ projectiles incident on carbon foils, NUCL INST B, 157(1-4), 1999, pp. 239-245
Citation: Ji. Juaristi et M. Rosler, Atomic number dependence of the forward/backward kinetic electron emissioninduced by slow ions in carbon foils, NUCL INST B, 157(1-4), 1999, pp. 254-258